Another American study performed molecular testing on 1286 consecutive metastatic CRC from 1271 patients as part of routine clinical care, and RAS amplification was detected in and included: KRAS, NRAS and HRAS for 15, 5 and 2 cases, respectively [49]. Here, HRAS is linked to colorectal carcinoma.